(2S,3S,4S,5R,6R)-6-[[(1R,2R,4R,6S,7S,10R,11R,14S)-17-acetyloxy-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-18-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadeca-12,16-dien-14-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C34H42O12 — CID 163025080
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3S,4S,5R,6R)-6-[[(1R,2R,4R,6S,7S,10R,11R,14S)-17-acetyloxy-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-18-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadeca-12,16-dien-14-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2S,3S,4S,5R,6R)-6-[[(1R,2R,4R,6S,7S,10R,11R,14S)-17-acetyloxy-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-18-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadeca-12,16-dien-14-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid (PubChem CID 163025080) has the molecular formula C34H42O12 and a molecular weight of 642.70 g/mol. Its IUPAC name is (2S,3S,4S,5R,6R)-6-[[(1R,2R,4R,6S,7S,10R,11R,14S)-17-acetyloxy-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-18-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadeca-12,16-dien-14-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.
Molecular Properties
| Compound Name | (2S,3S,4S,5R,6R)-6-[[(1R,2R,4R,6S,7S,10R,11R,14S)-17-acetyloxy-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-18-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadeca-12,16-dien-14-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|---|
| PubChem CID | 163025080 |
| Molecular Formula | C34H42O12 |
| Molecular Weight | 642.70 g/mol |
| Exact Mass | 642.27 |
| IUPAC Name | (2S,3S,4S,5R,6R)-6-[[(1R,2R,4R,6S,7S,10R,11R,14S)-17-acetyloxy-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-18-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadeca-12,16-dien-14-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
| SMILES | CC(=O)OC1=C2C(C)(C)[C@@H](O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@H](c4ccoc4)C[C@H]4O[C@]43[C@]2(C)C1=O |
| InChI | InChI=1S/C34H42O12/c1-15(35)43-25-26-30(2,3)19(44-29-23(38)21(36)22(37)24(45-29)28(40)41)8-10-31(26,4)18-7-11-32(5)17(16-9-12-42-14-16)13-20-34(32,46-20)33(18,6)27(25)39/h8-10,12,14,17-24,29,36-38H,7,11,13H2,1-6H3,(H,40,41)/t17-,18+,19-,20+,21-,22-,23+,24-,29+,31+,32-,33-,34+/m0/s1 |
| InChIKey | SRJWEYKLPFHLJV-MJSWHEGGSA-N |
| XLogP | 2.61 |
| TPSA | 185.49 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 642.70 |
| LogP ≤ 5 | 2.61 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163025080 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.